A Phase III randomized controlled trial of oral dydrogesterone versus intravaginal progesterone gel for luteal phase support in
Chinese mainland
IVF
dydrogesterone
luteal phase support
micronized vaginal progesterone gel
randomized clinical trial
Journal
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
ISSN: 1473-0766
Titre abrégé: Gynecol Endocrinol
Pays: England
ID NLM: 8807913
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
pubmed:
10
8
2019
medline:
20
11
2020
entrez:
10
8
2019
Statut:
ppublish
Résumé
Lotus II, a randomized, open-label, multicenter, international study compared the efficacy and safety of oral dydrogesterone versus micronized vaginal progesterone (MVP) gel for luteal support in IVF. A prespecified subgroup analysis was performed on 239 Chinese mainland subjects from the overall study population (
Identifiants
pubmed: 31397179
doi: 10.1080/09513590.2019.1645110
doi:
Substances chimiques
Gels
0
Progesterone
4G7DS2Q64Y
Dydrogesterone
90I02KLE8K
Types de publication
Clinical Trial, Phase III
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM